Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins

S R Patel1, H Q Ke, R Vanholder

  • 1Nephrology Division, University of Michigan Medical School, Ann Arbor 48109-0364, USA.

Insights

Renal failure reduces vitamin D receptor (VDR) DNA binding capacity, impairing calcitriol

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Renal Medicine

Background:

  • Calcitriol (1,25-dihydroxy-vitamin D3) genomic actions are mediated by the vitamin D receptor (VDR) binding to vitamin D response elements (VDREs).
  • Renal failure is characterized by resistance to calcitriol, but the underlying mechanisms remain unclear.

Purpose of the Study:

  • To investigate the effect of renal failure on VDR-VDRE binding capacity.
  • To identify potential inhibitory factors in uremic plasma affecting VDR function.

Main Methods:

  • Electrophoretic mobility shift assay (EMSA) to compare VDR DNA binding in normal and renal failure rats.
  • Incubation of normal VDRs with uremic plasma ultrafiltrate.
  • Reporter gene assays in transfected JEG-3 cells.

Main Results:

  • VDRs from renal failure rats exhibited 50% less DNA binding capacity compared to controls, despite similar calcitriol binding.
  • Uremic plasma ultrafiltrate significantly reduced VDR binding to the osteocalcin VDRE.
  • The inhibitory effect was specific to VDR, not retinoid X receptors, and blocked calcitriol-induced reporter gene activity.

Conclusions:

  • Uremic toxins may inhibit VDR-VDRE binding, contributing to calcitriol resistance in renal failure.
  • This impaired VDR function could explain the reduced efficacy of calcitriol in patients with kidney disease.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...